Urology

With an ever-growing world population and increasing life-expectancy, the incidence of different types of cancer is expected to rise in…

The term neurogenic bladder is defined as bladder dysfunction resulting from damage to the nerves that control the bladder in the…

The authors report the case of an 80-year-old Canadian male with a giant bladder stone who declined treatment. A bladder stone is…

Explore evolving perspectives on erectile dysfunction with Sam Ward, covering treatment optimisation, sildenafil ODFs, and breaking taboos.

Emerging Prostate Cancer Diagnostics: Hashim Ahmed. Chair and Professor of Urology, Imperial College London, UK..

Globally, there are more than 650,000 newly diagnosed cases of bladder cancer annually, with up to approximately 80% of these cases…

Evolving Prostate Cancer Therapy: Bertrand Tombal. Chairman, Division of Urology; Full Professor of Urology, Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium…..

Prostate cancer remains one of the most prevalent malignancies among men worldwide, underscoring the need for effective diagnostic…

This article has now been retracted and a retraction statement has been published.

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of gonadotropin…

Urological cancers are malignancies that affect the organs of the urinary system and male reproductive system. Of these, bladder cancer…

Urolithiasis is a highly prevalent and multifactorial disease, representing the most common urological condition globally. Its incidence…

Pain, increased bleeding, nerve damage, and, at worst, bladder rupture are a few of the potential consequences of undertreated post-partum…

Sarcomatous transformation of the angiomyolipoma (AML) is a rare event with a handful of cases reported in the literature.¹ It is marked by…

EMJ is pleased to welcome Marcus Drake, Professor of Neurological Urology at Imperial College London, UK, who shared insights into the…

EMJ is delighted to introduce Axel Heidenreich, Professor and Director at the University of Cologne, Germany, who spoke to us about…

The authors report a case of delayed transurethral resection of prostate (TURP) syndrome. A 60-year-old man was diagnosed with obstructive…

The objectives of this symposium were to improve attendees’ knowledge on ADT, including the different therapeutic options available…

The worldwide prevalence of benign prostatic hyperplasia (BPH) varies between 20–60% in men over 50 years. Similarly, about 50% of men…

Erection is a neurovascular response accompanied by the release of neurotransmitters. The penis is innervated by autonomic (sympathetic…

Vilaseca opened the meeting by reminding the audience that the management and treatment of advanced PCa has…

Bladder cancers are classified into muscle-invasive and non-muscle-invasive, the latter accounting for 75% of cases.1 Accurate and timely…

Catheters have been utilised since ancient times to assist individuals incapable of voluntarily emptying their bladder…

Ureteral fistulas are a rare occurrence, and are most commonly the result of iatrogenic trauma, although other causes include radiation…

Zinner syndrome (ZS) is a rare urogenital anomaly characterised by a triad of unilateral renal agenesis, ipsilateral seminal vesicle cyst…

Medicine is a second career for me. I was in graduate school at New York University (NYU), USA, doing interactive computer sculpture, but…

Radiotherapy plays an important role in organ preservation for bladder cancer. Delivering radiation accurately can be challenging, in part…

The optimal dressing is still unclear, despite hypospadias being one of the most prevalent surgical operations. Children’s dressing for…

Jas Singh – Assistant Professor of Surgery (Urology), McGill University, Montréal, Quebec, Canada. My interest in functional and…

With a pre-specified aim of improving the standard of care of those living with intermittent catheter use, a roundtable discussion led by…

This article details the use of androgen deprivation therapy in current clinical practice as discussed in an Accord Healthcare-sponsored symposium, delivered as part of the European Association of Urology (EAU) 38th Annual Congress held in Milan, Italy, between 10th–13th March 2023.

Juan Gómez Rivas | Urology Consultant, Hospital Clinico San Carlos, Madrid, Spain; Assistant Professor, Universidad Complutense de Madrid, Spain

Timothy Clinton – Urologic Oncologist and Associate Surgeon, Dana–Farber Cancer Institute and Brigham and Women’s Hospitals, Boston, Massachusetts, USA; Faculty Member, Harvard University, Boston, USA.

Kari Tikkinen – Professor of Urology, Department of Surgery, University of Helsinki, Finland; Consultant Urologic Surgeon at the Department of Urology, Helsinki University Hospital, Finland and the Department of Surgery, South Karelian Central Hospital, Finland

Bhaskar Somani – Professor and Consultant Urological Surgeon, University of Southampton, UK; Clinical Director of South Coast Lithotripter Services, UK; Endourology Lead, University Hospital Southampton, UK

Ben Challacombe |Consultant Urological Surgeon, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, UK. Having spent over 10 years in your current role with Guy’s and St Thomas’, what initially sparked your interest in urology and has pushed you to reach your established position today?

Bladder cancer (BC) is the fourth most common malignancy in males and shows high prevalence and mortality rates worldwide despite improvements in its management.

Testicular seminomas are the most common type of testicular germ cell tumours. It typically affects young males between the ages of 30–55 years. Because of its high sensitivity to chemotherapy and radiotherapy, these tumours have high cure rates.